Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates. - Wikidata - wikimedia - TriplyDB

Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.

Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.

http://www.wikidata.org/entity/Q34760675

about

Live attenuated vaccines for invasive Salmonella infections Vaccines against invasive Salmonella disease: current status and future directions Role of T3SS-1 SipD Protein in Protecting Mice against Non-typhoidal Salmonella Typhimurium The delicate balance in genetically engineering live vaccines.Flagellin as carrier and adjuvant in cocaine vaccine development.Sequence- and Structure-Based Immunoreactive Epitope Discovery for Burkholderia pseudomallei Flagellin Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.Functional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella.Invasive Nontyphoidal Salmonella Infections Among Children in Mali, 2002-2014: Microbiological and Epidemiologic Features Guide Vaccine Development.Modeling the Potential for Vaccination to Diminish the Burden of Invasive Non-typhoidal Salmonella Disease in Young Children in Mali, West Africa.Comparing the roles of antibodies to nontyphoidal Salmonella enterica in high- and low-income countries and implications for vaccine development.Outer membrane vesicles from flagellin-deficient Salmonella enterica serovar Typhimurium induce cross-reactive immunity and provide cross-protection against heterologous Salmonella challenge Protective Immunity Elicited by Oral Immunization of Mice with Salmonella enterica Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) Mutants.Igg Subclasses Targeting the Flagella of Salmonella enterica Serovar Typhimurium Can Mediate Phagocytosis and Bacterial Killing.Vaccination against Salmonella Infection: the Mucosal Way.Preventing invasive salmonellosis in children through vaccination.Recombinant attenuated Salmonella Typhimurium with heterologous expression of the Salmonella Choleraesuis O-polysaccharide: high immunogenicity and protection.Outer membrane vesicles derived from Salmonella Typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model.Opsonophagocytic Assay To Evaluate Immunogenicity of Nontyphoidal Salmonella Vaccines.A scalable method for biochemical purification of Salmonella flagellin.Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae.Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS:FliC glycoconjugates in infant and adult mice.

P2860

Q27003066-88324E31-0344-4A06-8606-2EB41ABCC4BC Q27007088-976D3CE0-CF2F-4F2F-9C0D-2191D9CB0E3E Q28354066-8413EF9B-7347-4DC8-BC71-7F0FB1ED3551 Q33801051-7BEE2BB7-6E8A-4094-A655-BE43C0F136F6 Q35057556-17D89BBD-80C8-4375-A712-657004A26312 Q35723661-409AC078-59C5-4D6E-83C0-3A1E0509776B Q35887055-9EF20228-AF6F-47EB-B4E2-615A42E6F192 Q35964671-F9EB1E57-BF43-43C6-94E7-7164EAC49B06 Q36133462-2852C79E-87F4-45FC-A808-D9A75DD5B12E Q36275289-D6F12DBC-6C7E-4651-AA4A-8EFF23BF454F Q37252383-AAF52EC7-84D4-45BB-A247-8B1982915D1D Q37307095-B6CE9147-1BBD-4686-AEA4-6635A654BCE7 Q37405767-A50D4CC6-6E1B-4359-A9CE-F9A3D8EAA242 Q38760495-FA8C572B-609E-4725-AF67-17170C21A862 Q39373957-A1773A15-EC82-47F7-9384-648EAE047F7B Q40107571-2B20904E-8B58-472E-B117-AFEE7D19AC1D Q40114957-3F89FDDD-7AD0-4804-9512-AD769315D932 Q40557181-26446AF9-1F81-4CB8-8A69-419B96BEB754 Q40734790-0C029533-F9D4-4643-80D6-EFD2B7CA6A3D Q42915324-6B7CB47A-18CB-43A8-BBDB-F33F15D321E0 Q47105309-3D01AD53-5279-4ADB-BC7B-0514DFC0ED3B Q54201279-7901DEAB-0A8F-472B-A450-6FD11E45B194

P2860

Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.

http://www.wikidata.org/entity/Q34760675

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Sustained protection in mice i ...... ide-flagellin glycoconjugates.

@ast

Sustained protection in mice i ...... ide-flagellin glycoconjugates.

@en

Sustained protection in mice i ...... ide-flagellin glycoconjugates.

@nl

type

label

Sustained protection in mice i ...... ide-flagellin glycoconjugates.

@ast

Sustained protection in mice i ...... ide-flagellin glycoconjugates.

@en

Sustained protection in mice i ...... ide-flagellin glycoconjugates.

@nl

prefLabel

Sustained protection in mice i ...... ide-flagellin glycoconjugates.

@ast

Sustained protection in mice i ...... ide-flagellin glycoconjugates.

@en

Sustained protection in mice i ...... ide-flagellin glycoconjugates.

@nl

P1433

Q34760675-425C1A61-4153-4C3B-9EE7-5B00FE10D57A

P1476

Q34760675-C1229907-3C2A-4308-8FC6-D6479EF13FC2

P2093

Q34760675-28151310-AF7F-4F78-8989-DBF846AE3A78

Q34760675-413C467B-71DC-42E0-9125-595D247D1E82

Q34760675-5ABFEA26-F541-4DA5-A6EB-02C8545EA39C

Q34760675-6F8F7652-4127-4C5B-AF0F-09E175D306BB

Q34760675-908AADB6-921D-4FAC-B1E3-46ED967FD7F4

Q34760675-BE20FF69-83A3-4A41-B671-C431318CDE73

Q34760675-C9304249-D97F-4767-8A46-E58F50FC5651

P2860

Q34760675-03A2B0DE-0E9A-47EE-8A42-52E7A5A30C0C

Q34760675-0516EEA8-3C91-4F0A-B291-CD9E9BD7BBD7

Q34760675-0D5B89E1-A421-42A2-BD5C-D79DFC6844BB

Q34760675-0F883A26-C435-4773-BD7E-DCBDADA071A6

Q34760675-1C7B9B82-2C66-41F2-BC39-04A78ECBBE29

Q34760675-38C753DA-FE50-4838-A710-0F63574BF372

Q34760675-3D054087-F898-43F8-B944-4EB66F1D1954

Q34760675-4A48F64F-BF54-4918-AA70-237745089DF1

Q34760675-4E216845-DFE6-4849-9F35-3B7E718CEE5A

Q34760675-51C44922-967A-41DE-8204-68B452C8F6D0

P304

Q34760675-BB1DCE06-43F4-4058-8B44-AC101EC26F32

P31

Q34760675-035E0D6E-49E0-4419-AAC1-64359CDBA21E

P356

Q34760675-32448032-B7B2-4FEC-B8EF-D514E6E28DF3

P407

Q34760675-775A4F7F-FF52-4BFE-A24B-553809A21CFF

P433

Q34760675-03848E35-B7D8-4FD1-A082-842A7B29E867

P478

Q34760675-6E3D4A0D-833B-4578-8094-02053355CB7B

P50

Q34760675-C7C81D3D-F724-4B81-ADCF-AB9D44E2CE99

Q34760675-D3BB8900-1BE2-4C41-9757-7DBD2E8347E8

P577

Q34760675-74509C86-2AA5-4C1D-BEE4-859E4D58F9FD

P5875

Q34760675-C898876D-B064-437D-A736-69FDD9D0AB07

P698

Q34760675-6E76C495-4FAE-4E7B-A891-3CB415303F84

P921

Q34760675-05099F9A-5A82-42E2-B090-CA03C36D6F77

Q34760675-5E4F4119-66E3-4266-8331-4B440684A1AA

P932

Q34760675-8E2FC10B-6A56-4FDE-A534-76CC9B1A7B28

P356

JOURNAL.PONE.0064680

P1433

P1476

Sustained protection in mice i ...... ride-flagellin glycoconjugates

@en

P2093

Girish Ramachandran

http://www.w3.org/2001/XMLSchema#string

James E Galen

http://www.w3.org/2001/XMLSchema#string

Jin Y Wang

http://www.w3.org/2001/XMLSchema#string

Mary A Boyd

http://www.w3.org/2001/XMLSchema#string

Mohan E Tulapurkar

http://www.w3.org/2001/XMLSchema#string

Raphael Simon

http://www.w3.org/2001/XMLSchema#string

Sharon M Tennant

http://www.w3.org/2001/XMLSchema#string

P2860

The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children

Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam.

A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION.

Absence of all components of the flagellar export and synthesis machinery differentially alters virulence of Salmonella enterica serovar Typhimurium in models of typhoid fever, survival in macrophages, tissue culture invasiveness, and calf enterocol

Detection of Vi-negative Salmonella enterica serovar typhi in the peripheral blood of patients with typhoid fever in the Faisalabad region of Pakistan.

Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium

Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa.

The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines.

P304

e64680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0064680

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Myron M. Levine

Marcela F Pasetti

P577

2013-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237061128

http://www.w3.org/2001/XMLSchema#string

P698

23741368

http://www.w3.org/2001/XMLSchema#string

P921

polysaccharides

P932

3669428

http://www.w3.org/2001/XMLSchema#string